Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
about
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer.High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients.Prognostic gene expression assays in breast cancer: are two better than one?An Update on Breast Cancer Multigene Prognostic Tests-Emergent Clinical BiomarkersClinical relevance of the 21-gene Recurrence Score assay in treatment decisions for patients with node-positive breast cancer in the genomic eraBreast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesisLuminal A Breast Cancer and Molecular Assays: A ReviewAn Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
P2860
Q44296908-6385C107-FA03-4D2D-AC8D-3CAC528B2EBAQ47612310-32A58296-FE72-47DE-973B-E4D21636047CQ47786696-E2042CC0-99CC-42D7-8431-1D4636F94CD9Q47821852-352B644E-0389-437C-A996-4B3F569AF4ACQ48353102-13EC6B30-E8F3-42D4-8A30-4130BB8E46DBQ54495437-651C7D7A-C818-47B8-AF8C-9EA299029159Q54987182-A8226816-2E51-4025-971B-824A1E61CE79Q55283234-EEF7B356-094A-43FB-87F4-EB1557FA5430Q55346547-C150CDF0-96DA-48A3-A552-24D69906D629Q57106403-B7A71AC2-B0D8-430B-BE1D-262B11D81C97Q57107755-76D2E036-3F2B-4CA6-857E-454603AC119EQ57112840-AC4319EF-D3A7-4EF2-8622-DBDA3CC58852Q57113322-252C55ED-8300-418D-9FF5-4C4E3D3A74B7Q59128489-DA15B7A6-76E6-49A6-B7E7-A1DDF9578E86
P2860
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Use of Biomarkers to Guide Dec ...... tice Guideline Focused Update.
@en
type
label
Use of Biomarkers to Guide Dec ...... tice Guideline Focused Update.
@en
prefLabel
Use of Biomarkers to Guide Dec ...... tice Guideline Focused Update.
@en
P2093
P2860
P356
P1476
Use of Biomarkers to Guide Dec ...... tice Guideline Focused Update.
@en
P2093
Antonio C Wolff
Catherine Van Poznak
Deborah E Collyar
Fabrice Andre
M Elizabeth Hammond
Minetta C Liu
Nicole M Kuderer
Nofisat Ismaila
Robert G Mennel
P2860
P304
P356
10.1200/JCO.2017.74.0472
P407
P577
2017-07-10T00:00:00Z